Pre-Evaluation and Evaluation Timelines Under Nicaraguan Rules

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The correction mechanism for device registration in Nicaragua has two stages: a rejection at the pre-evaluation stage leaves 15 working days to correct (Article 3 of Chapter 7 of NTON 24001:2023); a rejection at the evaluation stage issues an Acta de Rechazo with 20 working days to correct, and no more than 2 rejections are permitted at that stage (Article 5 of Chapter 7, NOTA 2). If the two attempts fail or the correction is not filed in time, the application is cancelled (dar de baja), and a new submission must be made starting again from payment of the fee. RA 0007/2025 supplies two further figures: the DDM has 3 working days to review the pre-evaluation (Annex I, Article 11, item 4), and applications requiring samples have 3 working days to submit them after the pre-evaluation is passed (Article 11, item 9).

2. Legal basis

The correction windows come from the technical standard, while the procedural counts for the pre-evaluation come from the administrative decision. The key provisions are set out below.

LevelInstrumentProvisionKey point
Technical standardNTON 24001:2023, «Tecnología de la salud. Dispositivos médicos. Requisitos para el Registro Sanitario» (La Gaceta No. 192, 2024-10-21)Chapter 7, Article 3, with NOTA 1 and NOTA 2After rejection at pre-evaluation, 15 working days to correct or supplement; if not submitted in time or still non-compliant on review, the application is cancelled
Technical standardNTON 24001:2023Chapter 7, Article 5, with NOTA 2After rejection at evaluation, 20 working days to correct; no more than 2 rejections are permitted at this stage
Technical standardNTON 24001:2023Chapter 7, Article 5, NOTA 1 and NOTA 3Cancellation of the application where correction is not filed in time; cancellation where non-conformities persist after correction
Administrative decisionAdministrative Resolution No. 0007/2025 (in force from 2025-05-02)Annex I, Article 11, item 4The DDM has a 3-working-day review period for the registration pre-evaluation
Administrative decisionAdministrative Resolution No. 0007/2025 (in force from 2025-05-02)Annex I, Article 11, item 9After the pre-evaluation is passed, applications requiring samples have 3 working days to submit them
Administrative decisionAdministrative Resolution No. 0007/2025 (in force from 2025-05-02)Annex I, Article 12, items 1, 3 and 4The evaluation duration, the correction period and the number of rejections all refer back to the current NTON rules

3. Expert insights

Insight 1: the two stages have different correction windows and different limits on the number of rejections, and they cannot be interchanged. Pre-evaluation gives 15 working days with no stated cap on the number of attempts, but provides that the application is cancelled if it is still non-compliant on review (NOTA 2). Evaluation gives 20 working days and states explicitly «Se permitirá 2 rechazos por solicitud en esta etapa» — 2 rejections per application are permitted at this stage. Applying 20 days to the pre-evaluation, or 2 rejections to the pre-evaluation, will misstate the available room to operate.

Insight 2: RA 0007/2025 sits on top of the standard, wrapping procedure around it. Item 1 of Article 12 of Annex I states the evaluation duration as «el tiempo establecido en la normativa vigente» — the time established in the current regulatory framework — and items 3 and 4 likewise refer the correction period and the number of rejections back to NTON. That is to say, the duration of the evaluation itself is not explicitly stated in the current texts; this is a timeline gap verified in this volume, and no estimate is substituted for it.

Insight 3: the price of cancellation is paying again. Item 3 of Article 12 of Annex I states «deberá iniciar uno nuevo iniciando con el pago del arancel correspondiente» — a new application must be started, beginning with payment of the corresponding fee. Managing correction deadlines is therefore in substance managing cost: a single missed deadline writes off the fee already paid.

Insight 4: the pre-evaluation checks only that documents are complete. Article 2 of Chapter 7 says «se verifica el cumplimiento de los documentos requeridos» — a formal review — while the technical content belongs to the evaluation stage. A pre-evaluation rejection therefore normally signals missing documentation or a formal defect rather than a technical rejection, and that distinction determines how the correction team is staffed.

Insight 5: the sample window is a separate 3 working days. Item 9 of Article 11 of Annex I begins a fresh paragraph after the pre-evaluation is passed, giving applications that require samples 3 working days to submit them. This period does not overlap with the evaluation timeline, and it is a step commonly omitted from project schedules.

Insight 6: corrections can only be completed during the system’s working-day opening hours. Items n and o of Article 5 of Annex I restrict system availability to working days from 8:00 to 17:00, and corrections following a rejection must also be made within that window. The 15 or 20 «working days» are not 15 or 20 calendar days, and cross-timezone teams must schedule backwards against local hours.

4. Practical recommendations

  • Manage the correction windows stage by stage: 15 working days for pre-evaluation and 20 working days for evaluation, with expiry alerts set in the system.
  • Treat the number of rejections as a budget: the evaluation stage allows only 2, so the first rejection should be remedied to the standard of a final attempt.
  • When a pre-evaluation is rejected, start with a formal check against the 14-item documentation list of Chapter 6, rather than opening a technical argument at once.
  • Reserve the 3-working-day sample submission window for applications that require samples, and have the samples ready before the pre-evaluation is passed.
  • Schedule correction work within the system window of 8:00 to 17:00 on working days, avoiding time-zone risk on the final day.
  • Keep an overdue ledger: any cancellation means paying again, so monitor both the correction deadline and the 6-month validity of the fee payment receipt (Chapter 6, item 1).

5. Verification checklist

  • □ Set correction expiry alerts by stage: 15 working days for pre-evaluation and 20 working days for evaluation
  • □ Handled the first remediation to the standard of the only 2 rejections available at the evaluation stage
  • □ After a pre-evaluation rejection, carried out a formal check item by item against the 14-item documentation list of Chapter 6
  • □ Prepared samples for applications requiring them and reserved the 3-working-day submission window after the pre-evaluation is passed
  • □ Scheduled correction work within the system window of 8:00 to 17:00 on working days
  • □ Monitored both the correction deadline and the 6-month validity of the ROC payment receipt (Chapter 6, item 1)

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Nicaraguan market. Our team manages Ministry of Health (MINSA) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail